JENNIFER DUCK: Open Payments
NPI 1770762668 · NEW IBERIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 53 payments from 10 companies in 2025. Trend: 2023 $629 · 2024 $767 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $227 |
| Madrigal Pharmaceuticals | 10 | $153 |
| GENZYME CORPORATION | 3 | $97 |
| Janssen Biotech, Inc. | 3 | $92 |
| Ardelyx, Inc. | 3 | $60 |
| Gilead Sciences, Inc. | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| PFIZER INC. | 1 | $24 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, CREON, SKYRIZI, IBSRELA, RINVOQ, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
